{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-126869","form_type":"8-K","ticker":null,"cik":"0001657312","company_name":"Verona Pharma plc","filed_at":"2023-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.964399+00:00","generated_at":"2026-06-07T11:19:41.503970+00:00","sec_items":["4.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Verona Pharma dismisses PwC, appoints EY as auditor subject to 2024 AGM vote","bullets":["Audit committee dismissed PwC on Dec 14, 2023; approved EY engagement for FY 2024 subject to shareholder appointment at 2024 AGM.","No disagreements or reportable events between Verona and PwC during FY 2021-2022 and interim period through Dec 14, 2023.","PwC's reports on FY 2022 and FY 2021 financial statements were unqualified, containing no adverse opinion or modification."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-126869","json":"https://secwatch.observer/filing/0001104659-23-126869.json","markdown":"https://secwatch.observer/filing/0001104659-23-126869.md","text":"https://secwatch.observer/filing/0001104659-23-126869.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1657312/000110465923126869/0001104659-23-126869-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1657312/000110465923126869/tm2333000d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:19:41.503970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c2561f6c320d7cb04fb6ef4a7a4f9c504bf05489","claim":"Verona Pharma plc engaged Ernst & Young LLP as its auditor.","evidence_excerpt":"approved the engagement of Ernst & Young LLP (\"EY\") to serve as the Company’s independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465923126869/0001104659-23-126869-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Ernst & Young LLP"}],"fact_type":"auditor_change"},{"claim_id":"e68367139eeee0ea0f94b302179678461209cb15","claim":"Verona Pharma plc dismissed PricewaterhouseCoopers LLP as its auditor.","evidence_excerpt":"dismissed PricewaterhouseCoopers LLP (\"PwC\") and approved the engagement of Ernst & Young LLP (\"EY\") to serve as the Company’s independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1657312/000110465923126869/0001104659-23-126869-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"PricewaterhouseCoopers LLP"},{"label":"Successor","value":"Ernst & Young LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}